Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

57 results about "Hypericin" patented technology

Hypericin is a naphthodianthrone, an anthraquinone derivative which, together with hyperforin, is one of the principal active constituents of Hypericum (Saint John's wort). Hypericin is believed to act as an antibiotic, antiviral and non-specific kinase inhibitor. Hypericin may inhibit the action of the enzyme dopamine β-hydroxylase, leading to increased dopamine levels, although thus possibly decreasing norepinephrine and epinephrine.

Application of hypericin nanoparticles subjected to photodynamic treatment in preparation of drugs for inhibiting liver cancer cells

The invention provides application of hypericin nanoparticles subjected to photodynamic treatment in preparation of a medicine for inhibiting liver cancer cells. The hypericin nanoparticles (HC-NPs) are formed by wrapping a traditional Chinese medicine monomer hypericin (HC) with distearoyl phosphatidyl ethanolamine-polyethylene glycol 2000 (DSPE-PEG2000). The hypericin nano-particles provided by the invention have an obvious inhibition effect on liver cancer cells under a specific illumination condition, so that the expression of the gene SERPINE1 is up-regulated in a time-dependent and dose-dependent manner. The gene participates in regulation of biological behaviors of liver cancer, and provides a new view angle for treatment of liver cancer.
Owner:AFFILIATED HOSPITAL OF GUILIN MEDICAL UNIV

Application of hyperforin in preparation of medicine for preventing or treating amyotrophic lateral sclerosis

The invention belongs to the technical field of medicines, and discloses application of hyperforin in preparation of a medicine for preventing or treating amyotrophic lateral sclerosis. The hyperforin can improve the survival rate of stable transfection cell lines of amyotrophic lateral sclerosis related cell models (SOD1G93A / TDP43M337V), and the hyperforin is prompted to play a protective role in the two cell models. After the hyperforin is given, the expression levels of HO-1 and Drp1 proteins in SOD1G93A cells are increased, which indicates that the hyperforin has certain antioxidant activity; and mitochondrial division in cells can be inhibited, so that cell apoptosis is inhibited and retarded, and a protection effect is achieved. Hypericin can help to improve the SOD1G93A cell morphology and promote synaptic generation, and it is prompted that hypericin has a positive effect on maintaining normal functions of cells. In conclusion, the hyperforin plays a protective role in an SOD1G93A cell model and a TDP43M337V cell model, and the mechanism of the hyperforin is possibly related to the antioxidant activity, the mitochondrial function improvement and the like of the hyperforin.
Owner:INST OF MATERIA MEDICA CHINESE ACAD OF MEDICAL SCI

Self-assembly PROTAC nano material based on mitochondria targeting of natural product as well as preparation method and application of self-assembly PROTAC nano material

The invention discloses a self-assembled PROTAC nano material based on natural product mitochondria targeting, which is a nano particle prepared from mitochondria targeting molecules, a photosensitizer and PROTAC as raw materials through a nano precipitation method. The mitochondrial targeting molecule is berberine, the photosensitizer is hypericin, and the PROTAC is dBET57; the ratio of the amount of substance of the dBET57 to the amount of substance of the berberine is (1-10): (1-10), and the ratio of the amount of substance of the dBET57 to the amount of substance of the hypericin is (1-10): (1-10). The nano material can be used for blocking multiple energy metabolism pathways of tumor cells, including glycolysis and oxidative phosphorylation, meanwhile, mitochondria is damaged, ferroptosis is induced, and the anti-tumor capacity of pharmacodynamic molecules is improved; bRD4 in tumor cells and downstream carcinogenic protein c-Myc of the BRD4 can be efficiently degraded. The invention also discloses an application of the nano material in preparation of antitumor drugs.
Owner:FUJIAN UNIV OF TRADITIONAL CHINESE MEDICINE

Application of hypericin in preparation of medicine for treating liver cancer

The invention relates to the field of biological medicines, in particular to application of hypericin to preparation of a medicine for treating liver cancer. The invention provides application of hypericin in preparation of a medicine for treating liver cancer and a pharmaceutical composition containing the hypericin. The inventor finds that hypericin is used as a traditional Chinese medicine compound, in-vitro experiments prove that hypericin can inhibit liver cancer cell proliferation, inhibit liver cancer cell migration and induce liver cancer cell apoptosis, in-vivo experiments prove that hypericin can significantly inhibit liver tumor cell growth in mice, and it is indicated that hypericin can treat liver cancer. The traditional Chinese medicine composition can be used as a component in medicines for treating liver cancer.
Owner:INST OF HEALTH & MEDICINE HEFEI COMPREHENSIVE NAT SCI CENT

Nano-antibacterial material based on bisoxalate and hypericin as well as preparation method and application of nano-antibacterial material

The invention discloses a nano antibacterial material based on bisoxalate and hypericin as well as a preparation method and application of the nano antibacterial material, and belongs to the technical field of antibacterial agents. A supermolecule self-assembly method is used for organically combining a chemiluminescence agent CPPO and a photosensitizer hypericin, the chemiluminescence agent CPPO and the photosensitizer hypericin are tightly combined through chemical acting force, and the antibacterial nanometer material with the optimal size and dispersity is obtained by adjusting the ratio of the chemiluminescence agent CPPO and the photosensitizer hypericin. The antibacterial nano-material disclosed by the invention has excellent antibacterial biofilm performance generated by triple effects of deep permeation, production of active oxygen to kill bacteria and inhibition of H2S from damaging a self-defense mechanism of the bacteria, and still has a relatively good antibacterial effect on methicillin-resistant staphylococcus aureus at low concentration (2 mu g / mL).
Owner:ZHEJIANG CHINESE MEDICAL UNIVERSITY

Hypericin-PVP complex with high hypericin content

The invention relates to a complex that consists of hypericin or a hypericin salt and polyvinyl pyrrolidone (PVP), the average mass fraction of hypericin or hypericin salt in the entire complex being higher than 6% by weight. The invention further relates to a process for preparing said hypericin-PVP complex, according to which process a mixture of hypericin and PVP is heated to a temperature above the glass transition temperature of the PVP used.
Owner:HYPERICUM LIFESCIENCE GMBH

A method for preparing a fukekang composition and a detection method thereof

The present application relates to a kind of preparation method of Fugunkang composition and its detection method, the preparation method is cut into section, first using red koji and saccharomyces cerevisiae combined fermentation extraction, dregs is extracted with water before boiling, concentrate and extract the fermentation liquor and water, it is obtained.The metabolic function of microorganism is fully utilized, promote the release and absorption of effective components of traditional Chinese medicine in vivo, so as to improve the curative effect of traditional Chinese medicine, reduce the side effect of traditional Chinese medicine.The detection method includes spray agent in just bed, parsnip medicine thin layer identification and the content detection of rutin, hypericin;The thin layer identification can identify just bed and parsnip medicine under the same chromatographic condition, the content detection increases the content detection of hypericin on the basis of original, and the content of rutin and hypericin can be determined simultaneously, save the detection cost, ensure the quality of raw material and finished product.
Owner:GUIZHOU LIANGJI PHARMA

Application of hypericin in preparation of product for treating calcified aortic valve disease

The invention discloses application of hypericin in preparation of a product for treating calcified aortic valve diseases, and belongs to the technical field of biological medicines. The present invention screens 260 mitochondrial-related compounds approved by the American Food and Drug Administration (FDA) to identify potential therapeutic agents. We employ a high content cell imaging system to assess the effects of these compounds on the expression levels of PGC-1 [alpha] and Runx2, where hypericin shows the most significant increase in the PGC-1 [alpha] / Runx2 ratio. After 52-week-old mice are subjected to western diet and intraperitoneal injection of 2.5 mg / kg hypericin once every other day, compared with a normal saline intraperitoneal injection group, the calcification degree of the valves of the mice supplemented with the hypericin is remarkably reduced after 16 weeks.
Owner:XIEHE HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI & TECH UNIV

Enzyme response type chemiluminescent nanoparticle for cancer imaging and in-situ photodynamic therapy as well as preparation method and application of enzyme response type chemiluminescent nanoparticle

The invention discloses a cathepsin B activated chemiluminescent nanoparticle. The cathepsin B activated chemiluminescent nanoparticle is prepared from cat B-C-550, hypericin and DSPE-mPEG2000 (Distearoyl Phosphate Polyethylene-mPEG (Polyethylene Glycol) 2000 in a self-assembly manner; the structure of the cat B-C-550 is as shown in a formula I in the specification. The invention discloses an application of cat B enzyme activated chemiluminescent nanoparticles in preparation of reagents or drugs for screening or diagnosing tumors. The invention discloses an application of cat B enzyme activated chemiluminescent nanoparticles in preparation of a cancer imaging reagent and / or a medicine for treating tumors. According to the invention, chemiluminescence imaging and in-situ cancer PDT treatment without external exciting light are realized. The cat B enzyme response type chemiluminescent nanoparticles are high in stability and can be effectively targeted and enriched at tumor focus parts.
Owner:CHINA PHARM UNIV

Application of hypericin-derived carbon dots in colorimetric detection of total antioxidant capacity

PendingCN123029013AFragariaUltraviolet lights
The application discloses application of ariophyllum viceroy flower derived carbon dots in colorimetric detection of total antioxidant capacity (TAC). The application takes ariophyllum viceroy flower as a precursor, and prepares carbon dots (CDs) with light response oxidase activity through one-step hydrothermal method. The catalytic activity of the CDs follows the Michaelis equation. The prepared CDs can catalyze colorless 3,3',5,5T-tetramethylbenzidine (TMB) to be oxidized into blue oxTMB under ultraviolet light irradiation, and generate characteristic ultraviolet absorption. Based on the reduction of antioxidants on oxTMB, the ultraviolet absorbance is reduced, and the solution color is lightened, and a colorimetric detection TAC platform is constructed. The platform takes ascorbic acid as a model, has a good linear response in the range of 0.05-10.0 muM of the concentration of the ascorbic acid, has anti-interference ability on common ions and amino acids, and is successfully applied to detection of TAC in actual samples such as tomatoes, grapefruits and strawberries. The method has the advantages of green raw materials, simple preparation, convenient operation and high sensitivity, and has wide application prospect in the fields of food analysis and biological detection.
Owner:JIAXING UNIV

Application of hypericin in preparation of medicine for pathological scars

The invention provides application of hypericin in preparation of a medicine for pathological scars, and relates to the technical field of biology. According to the application, hypericin is applied to preparation of the medicine for treating and / or preventing pathological scars of subjects. And / or preparing a drug for down-regulating at least one of type I collagen, type III collagen and phosphorylated SMAD2 protein of a subject; and / or down-regulating at least one of type I collagen, type III collagen and phosphorylated SMAD2 protein in the subject for non-diagnostic and therapeutic purposes. The application provides an effective component which is safe and reliable, has a definite curative effect, is easy to prepare and is used for treating and / or preventing dermatologic scars.
Owner:DERMATOLOGY HOSPITAL SOUTHERN MEDICAL UNIV (GUANGDONG PROVINCIAL DERMATOLOGY HOSPITAL GUANGDONG PROVINCIAL CENT FOR STI & SKIN DISEASES CONTROL & PREVENTION RES CENT FOR LEPROSY CONTROL & PREVENTION CHINA)

Use of active ingredient hypericin in hypericum perforatum in preparation of anti-migraine drugs

PendingCN122624445AHypericinAntimigraine drug
The application discloses application of an active ingredient hypericin in Hypericum perforatum in preparation of anti-migraine drugs, relates to the technical field of medicines, and identifies the active ingredient hypericin that can enter the brain from Hypericum perforatum extract, further combines BV2 cell in-vitro anti-inflammatory experiments, and analyzes blood rheology indexes of cerebral blood vessels and blood stasis changes after drug administration of rats, and confirms that the hypericin has good anti-migraine effect. The application provides definite experimental basis for the application of the active ingredient in anti-migraine drugs.
Owner:JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE +1

A composition with whitening and anti-aging effects, preparation method and application thereof

ActiveCN119235892BInhibits tyrosinase activityreduce melaninCosmetic preparationsToilet preparationsFuranEfficacy
The present invention provides a composition with whitening and anti-aging effects, a preparation method and application thereof, and belongs to the technical field of medicine or cosmetics. The composition comprises: cucurbitacin F, sutherlandin-5-trans-p-coumarate, quercetin, rutin, wogonin, trifoliol, quercetin-3-O-β-D-xyloside, scutellariae, hyperoside, cinchona sucretin Ib, kaempferol-3-furanarabinoside, arbutin and astragalus glycoside. The composition has significant whitening and anti-freckle effects, anti-aging effects, and is suitable for various skin types such as dry, oily, mixed and sensitive skin, and has high biological application value in the field of cosmetics and medicine.
Owner:CHANGCHUN UNIV OF CHINESE MEDICINE +1

Composition for increasing muscle mass

The present invention concerns a method for preventing muscle injuries and / or fatigue in a subject comprising the step of simultaneously, separately, or sequentially administrating to a subject in need thereof an effective amount of i) at least 20-Hydroxyecdysone, ii) at least rosavin, iii) at least one Medium-chain triglycerides (MCTs) and unsaturated fatty acid enriched oil, and iv) optionally a pharmaceutically acceptable carrier.
Owner:ANJAC SAS

A same, 5-HTP, and st. john's wort compound nutritional supplement for emotional support and joint care

The present invention discloses a SAMe, 5-HTP, and St. John's wort compound nutritional supplement for emotional support and joint care, comprising 15-25 parts of S-adenosylmethionine, 5-10 parts of 5-hydroxytryptophan, 3-8 parts of St. John's wort extract, 8-15 parts of sodium chondroitin sulfate, 2-5 parts of sodium hyaluronate, 0.5-1.2 parts of vitamin B6, 1-3 parts of vitamin E, 4-9 parts of phosphatidylserine, and pharmaceutical excipients. The weight ratio of S-adenosylmethionine to 5-hydroxytryptophan is 3:1-5:2, the weight ratio of St. John's wort extract to 5-hydroxytryptophan is 0.6:1-0.8:1, and the weight ratio of the joint-care agents to the total core active ingredients is 10:3-20:3. The hypericin content in the St. John's wort extract is not less than 3%. By optimizing the component ratios and utilizing synergistic functional excipients, the present invention achieves dual synergy in emotional support and joint care, with high product stability and excellent bioavailability.
Owner:ZIRAOUI NOUR-EDDINE

Composite hydrogel dressing as well as preparation method and application thereof

The invention relates to a composite hydrogel dressing as well as a preparation method and application thereof, and relates to the technical field of medical wound dressings. The SF / SA-H hydrogel dressing is obtained by taking silk fibroin (SF) and sodium alginate (SA) as a mixed solvent, adding hyperoside, mixing, pouring at a constant temperature, curing and demolding, the dressing realizes dual synergistic effects of antibiosis and anti-inflammation, has the characteristics of easily available raw materials, convenience in production and high safety while meeting the curative effect of DFU wound treatment, and has a wide application prospect. Large-scale production and clinical transformation are easy to realize, and the method has a wide medical application prospect.
Owner:CHONGQING MEDICAL UNIVERSITY

Application of hypericin in the preparation of drugs for pathological scar

The present invention provides an application of hypericin in the preparation of a drug for pathological scars, which relates to the field of biotechnology. The application includes applying hypericin to the preparation of a drug for treating and / or preventing pathological scars in a subject; and / or, preparing a drug for down-regulating at least one of type I collagen, type III collagen and phosphorylated SMAD2 protein in a subject; and / or, down-regulating at least one of type I collagen, type III collagen and phosphorylated SMAD2 protein in a subject for non-diagnostic and therapeutic purposes. The application provides an effective ingredient of a safe, reliable, and easy-to-prepare drug for treating and / or preventing skin pathological scars with definite curative effects.
Owner:DERMATOLOGY HOSPITAL SOUTHERN MEDICAL UNIV (GUANGDONG PROVINCIAL DERMATOLOGY HOSPITAL GUANGDONG PROVINCIAL CENT FOR STI & SKIN DISEASES CONTROL & PREVENTION RES CENT FOR LEPROSY CONTROL & PREVENTION CHINA)

Hypericin-PVP complex with high hypericin content

The invention relates to a complex that consists of hypericin or a hypericin salt and polyvinyl pyrrolidone (PVP), the average mass fraction of hypericin or hypericin salt in the entire complex being higher than 6% by weight. The invention further relates to a process for preparing said hypericin-PVP complex, according to which process a mixture of hypericin and PVP is heated to a temperature above the glass transition temperature of the PVP used.
Owner:HYPERICUM LIFESCIENCE GMBH

Ion pair engineered nanoassemblies inducing type i and ii immunogenic cell death and construction and use thereof

The application belongs to the field of new adjuvants and new dosage forms of pharmaceutical preparations, and particularly relates to a type I and type II immunogenic cell death inducer ion pairing engineered nanoassemblies as well as construction and application thereof. The nanoassemblies are composed of type I ICD inducers, type II ICD inducers, hydrophobic auxiliary counterions and amphiphilic lipid ion pairing. The type I ICD inducer is selected from mitoxantrone, doxorubicin, oxaliplatin or cyclophosphamide; the type II ICD inducer is selected from hypericin; and the hydrophobic auxiliary counterion is selected from cholesteryl sodium sulfate, cholic acid, deoxycholic acid, chenodeoxycholic acid, lithocholic acid, glycolcholic acid, taurocholic acid, glycochenodeoxycholic acid, taurochenodeoxycholic acid, deoxycholic acid lysine derivative, oleanolic acid and ursolic acid. The type I and type II ICD inducers are combined in the application, and have a synergistic tumor treatment effect.
Owner:SHENYANG PHARMA UNIV

Low-grade inflammation compositions

The present disclosure is related to dietary supplements. For example, this disclosure relates to compositions that include, one or more agents that decrease the production of tumor necrosis factor-alpha (TNF-α), decrease the CCL2, and decrease the interleukin-1 beta (IL-1β) responsible for low grade chronic inflammation.In some embodiments, the composition comprises: epicatechin present in an amount of about 0.25% to about 1% w / w of the composition; EGCG present in an amount of about 0.01% to about 0.1% w / w of the composition; lycopene present in an amount of about 1% to about 3% w / w of the composition; quercetin present in an amount of about 0.1% to about 1% w / w of the composition; luteolin present in an amount of about 0.1% to about 1% w / w of the composition; vitamin A present in an amount of about 1% to about 7.5% w / w of the composition; vitamin C present in an amount of about 40% to about 77% w / w of the composition; and vitamin E present in an amount of about 15% to about 40% w / w of the composition. Such compositions are useful for improving LGCI by decreasing TNF-α, CCL2, and IL-1β concentration.
Owner:CYTOSOLVE INC

New application of hypericin in preparation of medicine for preventing or treating Zika virus infection

The invention provides application of hypericin in preparation of a medicine for preventing or treating infection or diseases caused by Zika viruses, and further provides a medicine composition for preventing or treating infection or diseases caused by Zika viruses, and the medicine composition comprises effective dose of hypericin, at least one medicinal carrier and / or at least one medicinal auxiliary material. The hypericin is found to be capable of effectively inhibiting the Zika virus RNA replication effect and / or inhibiting the protein function (such as expression of envelope E protein) of the Zika virus for the first time, it is proved that the hypericin has the potential effect of preventing or treating infection or diseases caused by the Zika virus, and a new scheme is provided for preventing or treating the Zika virus. More potential use values of the hypericin can be explored, and a new direction is also provided for a scheme of anti-mosquito-borne virus drugs.
Owner:SOUTHERN MEDICAL UNIVERSITY

Antithrombin III determination kit

The invention provides an antithrombin III determination kit, and belongs to the technical field of in-vitro detection.The kit comprises a reagent R1 and a reagent R2, the reagent R1 comprises thrombin, benzamidine hydrochloride, hypericin and a reaction regulator, the reaction regulator is glycine and at least one of potassium chloride, sodium chloride, potassium sulfate and ammonium sulfate, and the reagent R2 comprises a reagent R1 and a reagent R2. The reagent R2 comprises a chromophoric substrate. In the kit disclosed by the invention, instantaneous inhibition of benzamidine hydrochloride added into the reagent R1 on thrombin and long-acting stabilization of hypericin are complementary, so that the stability of the reagent can be effectively improved, and meanwhile, the kit has good accuracy and repeatability and a relatively wide linear range; a new idea is provided for solving the stability problem of an antithrombin III activity detection reagent based on a chromophoric substrate method.
Owner:WUHAN EASYDIAGNOSIS BIOMEDICINE

Compositions that protect cells from oxidative and mitochondrial stress

PendingUS20260090969A1Organic active ingredientsCosmetic preparationsAcacetinLuteolinidin
There are described compositions comprising an effective amount of a combination of two or more components, said components selected from acacetin, ACTI peptide, alpha-lipolic acid, alprostadil, anisomycin, apigenin, ascorbic acid, astragalus, berberine, β-lapachone, β-hydroxy-beta-methyl-butyrate, Bacopa monnieri, catechin, catechol, chamomile, chrysin, coumestrol, curcumin, dinitrophenol, dinoprost, ellagic acid, (−)-epigallocatechin gallate, green tea extract, fisetin, genistein, ginsenoside RE, glabridin, 18-α-glycyrrhetinic acid, 18-β-glycyrrhetinic acid, glycyrrhizin, hydroquinone, isoquercitrin (EMIQ), kaempferol, kuromanin, leucine, lithium, luteolin, luteolin, luteolinidin, melatonin, menadione, 1-methylnicotinamide (MNA), methyl salicylate, myricetin, nadide, niacin (vitamin B3), nicotinamide (NAM), nicotinamide mononucleotide (NMN), nicotinamide riboside (NR), nicotinic acid adenine dinucleotide (NaAD), nicotinic acid mononucleotide (NaMN), parsley (Petroselinium crispum), phenylephrine, pokeweed mitogen, 15-Δ prostaglandin J2, puromycin, quercetin, quinolinic acid, retinoic acid, trichostatin A, troxrutin, rutin, tryptophan, vitamin D3, withaferin A, wortmannin and zinc (including salts thereof).
Owner:NUCHIDO LTD

Use of hypericin in regulating plant flowering and podding

The present invention discloses the use of hypericin in regulating plant flowering and podding, belonging to the technical field of plant growth regulators. When the concentration of hypericin is 1-5×10 ‑5 mg / L, especially when the concentration is 1×10 ‑3 -2×10 ‑4 mg / L and 2×10 ‑3 -1×10 ‑ 3 mg / L, it can effectively promote plant flowering and podding. The present invention discovers that hypericin can promote plant flowering and increase the podding rate of plants, mainly by regulating the degradation and synthesis of chlorophyll in plants, enhancing or weakening the photosynthesis of leaves, and regulating energy metabolism, thereby inhibiting or promoting plant flowering and controlling podding.
Owner:SICHUAN AGRI UNIV

Application of hyperoside in preparation of medicine for preventing and treating brain aging

The invention relates to application of hyperoside in preparation of drugs for preventing and treating brain senescence, experiments prove that the hyperoside can delay aging of astroglia cells by improving AQP4 polarity in a targeted mode, a new treatment approach is provided for delaying brain senescence and preventing and treating related nervous system diseases, research on pharmacological action of the hyperoside is expanded, and the application of the hyperoside in preparation of the drugs for preventing and treating the brain senescence is developed. And a theoretical basis is also provided for developing novel anti-brain aging drugs.
Owner:SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI

Method for preparing high-purity hypericin through counter-current chromatography

PendingCN120483865AQuinone separation/purificationBiotechnologyCountercurrent chromatography
Aiming at the three technical bottlenecks of low separation efficiency, high product purity and high solvent toxicity in the existing hypericin extraction and purification process, the mass transfer efficiency is improved through a steam explosion directional wall breaking technology, and the release efficiency of intracellular active ingredients is improved through multienzyme-ultrasonic coupling; multistage countercurrent chromatography separation is adopted to break through the selective limitation of traditional column chromatography on naphthdianthrone components, and the hypericin with the purity larger than or equal to 98% is finally obtained. The steam explosion technology is adopted, the dissolution rate of hypericin and other effective components is greatly increased, meanwhile, the extraction rate is increased, the yield is increased, and the cost is saved. According to the method, multienzyme-ultrasonic coupling and counter-current chromatography are combined, the problems of high energy consumption, high pollution and the like caused by strong acid (alkali) in a traditional plant extraction technology are integrally solved, oxidative deterioration caused by long-time heating of active ingredients is improved, meanwhile, the product purity is remarkably improved, and the method is suitable for industrial production. And a technical support is provided for construction of extraction production of clean, stable and high-quality natural products.
Owner:CHONGQING UNIV OF TRADITIONAL CHINESE MEDICINE

I-type and II-type immunogenic cell death inducer ion pairing engineered nano assembly and construction and application of I-type and II-type immunogenic cell death inducer ion pairing engineered nano assembly

The invention belongs to the field of new auxiliary materials and new dosage forms of pharmaceutical preparations, and particularly relates to an I-type and II-type immunogen cell death inducer ion pairing engineering nano assembly and construction and application thereof. The nano assembly is formed by pairing an I-type ICD inducer, an II-type ICD inducer, hydrophobic auxiliary counter ions and amphiphilic lipid ions; the I-type ICD inducer is selected from mitoxantrone, adriamycin, oxaliplatin or cyclophosphamide; the type II ICD inducer is selected from hypericin; the hydrophobic auxiliary counter ions are selected from sodium cholesterol sulfate, cholic acid, deoxycholic acid, chenodeoxycholic acid, lithocholic acid, glycocholic acid, taurocholic acid, glycochenodeoxycholic acid, taurochenodeoxycholic acid, deoxycholic acid lysine derivatives, oleanolic acid and ursolic acid. The I-type ICD inducer and the II-type ICD inducer are combined for use, and the synergistic tumor treatment effect is achieved.
Owner:SHENYANG PHARMA UNIV